MagnetisMM-32
Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refractory Multiple Myeloma
Arms / Cohorts
Experimental:Experimental Group : Elranatamab
Accepting patients
Active Comparator:Comparator Group: Elotuzumab, Pomalidomide and Dexamethasone
Accepting patients
Comparator Group:Comparator Group: Pomalidomide, Bortezomib and Dexamethasone
Accepting patients
Comparator Group:Comparator Group: Carfilzomib and Dexamethasone
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.